Paolo Ghia: Ibrutinib Plus Venetoclax Produces Deep Responses in Patients with CLL/SLL
Here, Paolo Ghia, MD, PhD, of Vita-Salute San Raffaele University in Milan, Italy, discusses recent findings from the phase II CAPTIVATE study evaluating fixed-duration...
Vincent Wagner and Ellen Marcus: Use of the Khorana Score to Predict VTE
Vincent Wagner, MD, and Ellen Marcus, BA, discuss the Khorana score's role in assessing risk of venous thromboembolism (VTE) in patients with gynecological cancers.
Curtis Andrew Lachowiez: Ivosidenib + Venetoclax and Azacitidine in IDH-Mutated Myeloid Malignancies
In this video, Curtis Andrew Lachowiez, MD, discusses interim results from a small study of patients with IDH1-mutated myeloid malignancies who were treated with ivosidenib plus...
Saad Usmani: Updated Results from the CARTITUDE-1 Trial in Patients with Heavily Pretreated Myeloma
In this video, Saad Z. Usmani, MBA, MD, discusses updated results from the CARTITUDE-1 trial evaluating ciltacabtagene autoleucel in patients with relapsed/refractory multiple myeloma.
Deepu Madduri: Ciltacabtagene Autoleucel in Relapsed/Refractory Multiple Myeloma
Deepu Madduri, MD, discusses data from the phase Ib/II CARTITUDE-1 study evaluating chimeric antigen receptor (CAR) T cell therapy ciltacabtagene autoleucel in patients with...
Steven Pipe: Etranacogene Dezaparvovec Gene Therapy for Hemophilia B
Steven Pipe, MD, shares safety and efficacy data from a phase III study of etranacogene dezaparvovec gene therapy in patients with hemophilia B.
Charlotte Bradbury: Adding Mycophenolate to Corticosteroid for ITP
Mycophenolate alongside corticosteroids may be considered as an effective first-line treatment option for some patients with immune thrombocytopenia. Charlotte Bradbury, MD, discusses results from...
José Blanco: Accessory Splenectomy in Patients with Immune Cytopenias
José Blanco, MD, discusses whether searching for an accessory spleen or performing accessory splenectomy is a safe and effective treatment for patients with refractory...
Anthony Mato: LOXO-305 Demonstrates Efficacy in Patients With CLL/SLL
Anthony Mato, MD, shares findings from a phase I/II trial evaluating LOXO-305 in patients with heavily pretreated chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL).
Tippi MacKenzie: In Utero Hematopoietic Cell Transplantation for Hematologic Conditions
In utero hematopoietic cell transplantation showed promise in a phase 1 clinical trial involving fetuses with alpha thalassemia major. Here, Tippi Mackenzie, MD, discusses...
Current Issue
July 2021 Bonus Mid-Year Edition, Volume 7 Issue 9
This issue features conversations with ASH Clinical Research Training Institute graduates, highlights from the virtual ASCO and EHA annual meetings, and more.